KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$58.60
+1.67 (+2.93%)
Performance
1D
—
1W
—
1M
—
3M
+32.13%
6M
+48.35%
1Y
+125.12%
YTD
+39.51%
Open$57.06
Previous Close$56.93
Day High$58.85
Day Low$56.83
52W High$58.26
52W Low$24.85
Volume—
Avg Volume1.09M
Market Cap4.51B
P/E Ratio76.41
EPS$0.74
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.51
Above
SMA 200
$35.71
Above
RSI (14)
68.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
+24.0% upside
Current
$58.60
$58.60
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 660.05M | 453.80M | 434.64M |
| Net Income | 57.48M | 35.57M | -80,259,876 |
| Profit Margin | 8.7% | 8.3% | -18.5% |
| EBITDA | 76.74M | 50.12M | -90,838,119 |
| Free Cash Flow | — | — | -118,111,706 |
| Rev Growth | +45.5% | +45.5% | +6.7% |
| Debt/Equity | — | — | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $201.55 | -0.57% | 88.1 | 372.29B |
| AMGN | Amgen Inc | $331.70 | +0.79% | 22.7 | 176.88B |
| GILD | Gilead Sciences Inc | $131.33 | -2.04% | 19.3 | 163.92B |
| VRTX | Vertex Pharmaceuticals Inc | $429.82 | +1.13% | 27.7 | 109.50B |
| REGN | Regeneron Pharmaceuticals | $714.89 | +0.82% | 16.5 | 74.30B |
| ALNY | Alnylam Pharmaceuticals Inc | $295.05 | -0.29% | 130.4 | 40.90B |